New radiation technique to reduce dry mouth in nasopharyngeal cancer
Part of Cancer, Ear, nose & throat clinical trials.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a newly diagnosed type of nasopharyngeal cancer called non-keratinizing carcinoma.
- You must be between 18 and 70 years old.
- You must be in good general health (able to do normal daily activities).
- Your cancer must be stage I to IVa (not spread too far).
- You cannot have had any prior cancer treatment like radiation or chemotherapy.
- You must have normal blood counts, kidney, and liver function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging (MRI scans) to see how radiation therapy affects the salivary glands in people being treated for nasopharyngeal cancer. The goal is to find better ways to prevent or manage dry mouth and other side effects.
This trial tests a new way to shape the radiation field for nasopharyngeal cancer that has spread into the nasal cavity. The goal is to reduce radiation to the nose while still effectively treating the cancer.
This trial compares two approaches for people with early-stage nasopharyngeal cancer that can be removed with surgery. It tests whether giving less intense chemotherapy and radiation after surgery works as well as a standard dose, with fewer side effects.
This Phase 1 study tests whether a citrus-flavored supplement (d-limonene gelcaps) can help prevent or reduce dry mouth (xerostomia) in people getting radiation plus chemotherapy for certain head and neck cancers. It aims to see how well the approach is tolerated and whether it can protect saliva function during treatment.
This trial compares two treatments—a salivary gland procedure (sialendoscopy) and a light therapy (photobiomodulation)—to prevent dry mouth caused by radiation therapy for head and neck cancer. If you are about to start radiation and meet the dose limits, you may be eligible.
This trial tests whether spermidine (a natural compound) can help prevent dry mouth caused by radiation treatment for head and neck cancer. It is for patients who will receive a significant dose of radiation to their saliva glands.
Hear when a new Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.